KLK3 and prostate carcinoma: Therefore, this study aimed to (1) determine the proportion of patients with high-risk prostate cancer (HR-PCa) who experienced spontaneous PSA decline after CIRT, following fulfillment of the Phoenix criteria, and (2) assess the validity of those criteria for guiding salvage treatment initiation.